APPLICATION OF MIRTAZAPINE IN CHRONIC PAIN SYNDROME



Chop etilgan sana:

PDF
Arslonova Rayhon Razhabboyevna
Samarkand State Medical University, Department of Pharmacology, Assistant
Uzoqova Mehribon Akmal kizi
Samarkand State Medical University Treatment faculty 2of course
Ergashov Saddam Rakhmatovich
Samarkand State Medical University Treatment faculty 3of course

Abstract

Chronic pain syndrome is a disease characterized by persistent, poorly treatable pain syndrome lasting more than 6 months. Such pain syndrome in most cases is the result of somatic disease or trauma. The main cause of chronic pain syndrome is long-term persistent pain, which causes an imbalance in the peripheral and central nervous system. Neuronal receptors and fibers in this case are subjected to constant activation, which leads to increased stimulation of the central nervous system (spinal cord and brain) by pain stimuli. One of the main causes of chronic pain is the appearance of complexes of hyperreactive neurons at various levels of the CNS. Their pathologic activity is caused by the breakdown of neuronal inhibition mechanisms, increased excitability of neurons and activation of inactive synapses, which unites these neurons into a single focus of excitation with self-sustained ectopic activity. This activity leads to functional, structural, and adaptive (neuroplastic) changes in the brain and spinal cord, causing pain to persist even when its cause is eliminated. There are many medications currently used to treat chronic pain, one of which is the widely used mirtazapine.

Foydalangan adabiyotlar

1. References
2. Raja S.N., Carr D.B., Cohen M. et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020; 161(9): 1976-82 Артеменко А.Р., Вейн А.М., Вознесенская Т.Г., Голубев В.Л. и др. Болевые синдромы в неврологической практике. 3-е изд., перераб. и доп. – М.: МЕДпресс-информ, 2010. – 336 С. Данилов А.Б., Данилов Ал.Б., Управление болью.
3. Фармакотерапия хронического болевого синдрома у онкологических пациентов. – М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «ФМИЦ им. П.А. Герцена» Минздрава России. - 2015.-илл. - 48 с.
4. Биопсихосоциальный подход.-М.: «АММ ПРЕСС».- 2012.-568 С. Данилов А.Б., Данилов Ал.Б., Биопсихосоциокультурная модель и хроническая боль. Современная терапия в психиатрии и неврологии. -№ 1.- 2013.- С. 30-36.
5. Крыжановский Г.Н. Центральные патофизиологические механизмы патологической боли. Тезисы докл. научно-практической конференции с международным участием Клинические и теоретические аспекты боли. М.: – 2001. – С. 14.
6. Raja S.N., Carr D.B., Cohen M. et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020; 161(9): 1976 – 82 2.
7. Артеменко А.Р., Вейн А.М., Вознесенская Т.Г., Голубев В.Л. и др. Болевые синдромы в неврологической практике. 3-е изд., перераб. и доп. – М.: МЕДпресс-информ, 2010. – 336 С. 3. 6.Данилов А.Б., Данилов Ал.Б., Управление болью. Биопсихосоциальный подход.-М.: "АММ ПРЕСС". 2012. – 568 С.
8. Данилов А.Б., Данилов Ал.Б., Биопсихосоциокультурная модель и хроническая боль. Современная терапия в психиатрии и неврологии. – N 1. – 2013. – С. 30-36.
9. Крыжановский Г.Н. Центральные патофизиологические механизмы патологической боли. Тезисы докл. научно-практической конференции с международным участием Клинические и теоретические аспекты боли. М.: – 2001. – С. 14.

Izlang

Izlash

Issue

Research Focus International Scientific Journal 4 (3)

Bo'lim

14.00.00 – Medical sciences

So'ngi nashrlar